IFRC


IFPMA and IFRC join forces to prevent non-communicable diseases

Publié: 19 mars 2013

Geneva, 19 March 2013 – The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) and the International Federation of Red Cross and Red Crescent Societies (IFRC) announced today a partnership on NCD prevention. The two-year partnership involves support from both organizations to design a behavioral change-based toolkit that promotes healthy lifestyle choices at national and community levels. Through its volunteer network and community-based expertise, the IFRC will make the toolkit available to approximately 3 million people worldwide.

The four main NCDs— cardiovascular diseases, cancer, chronic respiratory diseases and diabetes — kill three in five people worldwide, with 80 percent of NCD-related deaths occurring in low- and middle-income countries.

Because 50 percent of NCDs are avoidable, the IFPMA-IFRC partnership enhances efforts by both organizations to combat NCDs worldwide and support IFRC community interventions to reduce the impact of these diseases locally. Since releasing its Framework for Action on NCDs in 2011, IFPMA has delivered a series of research projects and health education initiatives to identify new ways to help people fight NCDs.

“By leveraging IFRC’s and IFPMA’s shared goal of fighting NCDs, this novel partnership brings synergy and creativity to fighting these diseases globally," says Eduardo Pisani, IFPMA Director General.

One of IFRC’s core strengths lies in community volunteers’ ability to tackle the underlying social, behavioral and environmental factors that determine good health through their on-the-ground work. “Changing behaviors by eliminating shared risk factors can save lives. Red Cross Red Crescent volunteers, going door-to-door in their communities play a vital role in promoting healthy lifestyles,” says Bekele Geleta, IFRC Secretary General. “But no one single player from the public or private sector working in silo can tackle the NCDs challenges. Fighting NCDs requires multi-stakeholders solutions.”

About the IFPMA:

IFPMA represents the research-based pharmaceutical companies and associations across the globe. The research-based pharmaceutical industry’s 1.3 million employees research, develop and provide medicines and vaccines that improve the life of patients worldwide. Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health community find solutions that improve global health.

 

For further information, please contact:

Peter Shelby, IFPMA

Tel +41/22 338 3223

Mob +41/79 820 2599

p.shelby@ifpma.org

 

Ali Karami-Ruiz, IFPMA

Tel +41/22 338 3229

Mob +41/78 850 2903

a.karami-ruiz@ifpma.org

Carte


La Fédération internationale des Sociétés de la Croix-Rouge et du Croissant-Rouge constitue, avec ses 190 Sociétés nationales membres, le plus vaste réseau humanitaire du monde. En tant que membres du Mouvement international de la Croix-Rouge et du Croissant-Rouge, nous sommes guidés dans notre travail par sept Principes fondamentaux: humanité, impartialité, neutralité, indépendance, volontariat, unité et universalité.